Today
+0.11%
5 Days
-7.67%
1 Month
-36.75%
6 Months
+2.80%
Year to Date
+92.42%
1 Year
+26.25%
• Arm shares dropped amid sector-wide AI selloffs and high valuation pressures. • Qualcomm court disputes created uncertainty regarding high-margin licensing royalty revenues. • Institutional investors increased defensive options ahead of the upcoming quarterly earnings.
• Arm Holdings declined due to lingering legal uncertainty from its Qualcomm architectural licensing dispute. • Broader semiconductor sector selling and elevated valuation risks further compounded the downward price movement. • Derivative market activity showed increased protective put volume and rising implied volatility ahead of earnings.
• Arm shares declined due to legal disputes, high valuation, and sector profit-taking. • A Delaware jury found Arm breached its architectural license agreement with Qualcomm. • Technical indicators show a sell signal with the MACD at -15.714.
• Arm breached contractual commitments in the Qualcomm Delaware federal court jury ruling. • Arm expands into custom silicon design, introducing execution risks and competitive friction. • Arm reports $4.92B annual revenue and trades with an average analyst target.
• Qualcomm litigation risks create material uncertainty for Arm royalty revenue streams. • Expanding into silicon design increases operational execution risk and customer conflict. • Elevated valuation multiples and high equity beta amplify short-term downward volatility.
• Arm faces downward pressure from legal uncertainties and high-stakes Qualcomm trial deliberations. • Reports of potential acquisition discussions raise capital allocation concerns and valuation scrutiny. • Technical indicators show neutral MACD and RSI levels, with oversold Williams %R.


| Shareholders | Proportion |
|---|---|
| SB Investment Advisers (UK) Limited | 86.72% |
| Goldman Sachs & Company, Inc. | 0.36% |
| Invesco Capital Management (QQQ Trust) | 0.28% |
| Coatue Management, L.L.C. | 0.22% |
| Shareholder Types | Proportion |
|---|---|
| Private Equity | 86.72% |
| Investment Advisor | 4.06% |
| Investment Advisor/Hedge Fund | 1.45% |
| Research Firm | 1.28% |
Related Instruments